TY - JOUR A1 - Rishi, Pukhraj A1 - Das, Atheeswar A1 - Sarate, Pallavi A1 - Rishi, Ekta T1 - Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation Y1 - 2012/1/1 JF - Indian Journal of Ophthalmology JO - Indian J Ophthalmol SP - 60 EP - 63 VL - 60 IS - 1 UR - https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2012;volume=60;issue=1;spage=60;epage=63;aulast=Rishi DO - 10.4103/0301-4738.91351 N2 - A 69-year-old lady presented with complaints of decreased vision in left eye since one month. Best Corrected Visual Acuity (BCVA) was 6/18 in that eye. Fundus examination revealed non-central geographic atrophy and soft drusens at macula in both eyes. Temporal periphery of left eye revealed subretinal exudates with altered sub-RPE hemorrhage mimicking peripheral exudative hemorrhagic chorioretinopathy (PEHCR). Fundus Fluorescein Angiogram showed window defects at macula and blocked fluorescence at temporal periphery in left eye. However, Indocyanine green angiography (ICGA) revealed active peripheral choroidal polyps. The patient was successfully treated with intravitreal bevacizumab and ICGA-guided laser photocoagulation. 27 months after laser treatment, BCVA improved to 6/9. Rationale of consecutive anti-vascular endothelial growth factor (VEGF) treatment followed by more definitive laser photocoagulation is that anti-VEGF aids in resolution of subretinal fluid, thus making the polyp more amenable to focal laser photocoagulation which stabilizes the choroidal vasculature and prevents further leakage. ER -